Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis: week 96 results of a phase II, randomised, multicentre trial

被引：0
|
作者：
Kappos, L.
Li, D.
Calabresi, P.
O'Connor, P.
Bar-Or, A.
Barkhof, F.
Yin, M.
Leppert, D.
Glanzmann, R.
Tinbergen, J.
Hauser, S. L.
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ Toronto, Toronto, ON, Canada
[5] McGill Univ, Montreal, PQ, Canada
[6] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
[9] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P462
引用
收藏
页码：S194 / S195
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
    Kappos, Ludwig
    Gold, Ralf
    Miller, David H.
    MacManus, David G.
    Havrdova, Eva
    Limmroth, Volker
    Polman, Chris H.
    Schmierer, Klaus
    Yousry, Tarek A.
    Yang, Minhua
    Eraksoy, Mefkure
    Meluzinova, Eva
    Rektor, Ivan
    Dawson, Katherine T.
    Sandrock, Alfred W.
    O'Neill, Gilmore N.
    LANCET, 2008, 372 (9648): : 1463 - 1472
  • [32] Half-dose ocrelizumab in selected patients with relapsing-remitting multiple sclerosis
    Algahtani, Hussein
    Shirah, Bader
    Alqahtani, Abdulhadi
    Abdelghaffar, Nawal
    Makki, Samiah
    ACTA NEUROLOGICA BELGICA, 2024, 124 (01) : 303 - 306
  • [33] Evaluation of shorter infusion times with ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Vollmer, Timothy
    Alvarez, Enrique
    Nair, Kavita
    Cohen, Jeffrey
    Boster, Aaron
    Masterman, Donna
    Pradhan, Ashish
    Musch, Bruno
    Ma, Xiaoye
    Pei, Jinglan
    Moss, Brandon
    Weinstock-Guttman, Bianca
    Bermel, Robert
    NEUROLOGY, 2019, 92 (15)
  • [34] Non-inferiority of azathioprine versus β interferons for relapsing-remitting multiple sclerosis: a multicentre randomised trial
    Massacesi, L.
    Tramacere, I.
    Benedetti, M. D.
    Filippini, G.
    La Mantia, L.
    Solari, A.
    Milanese, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 187 - 188
  • [35] Ocrelizumab and Cladribine have Similar Efficacy and Safety in Naive Relapsing Remitting Multiple Sclerosis Patients
    Alroughani, R.
    Al-Hashel, J.
    Ahmed, S. Farouk
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 97 - 97
  • [36] Immunogenicity with peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis: 2-year data from the randomised phase 3, multicentre ADVANCE study in relapsing-remitting multiple sclerosis
    White, J. T.
    Kieseier, B. C.
    Newsome, S. D.
    Zhu, Y.
    Cui, Y.
    Seddighzadeh, A.
    Hung, S.
    Deykin, A.
    Subramanyam, M.
    JOURNAL OF NEUROLOGY, 2014, 261 : S234 - S234
  • [37] Immunogenicity with peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis: 2-year data from the randomised phase 3, multicentre ADVANCE study in relapsing-remitting multiple sclerosis
    White, J. T.
    Kieseier, B. C.
    Newsome, S. D.
    Zhu, Y.
    Cui, Y.
    Seddighzadeh, A.
    Hung, S.
    Deykin, A.
    Subramanyam, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 346 - 346
  • [38] Safety, pharmacodynamics, and activity of rituximab in patients with relapsing-remitting multiple sclerosis: a phase I, multicentre, open-label clinical trial
    Bar-Or, A.
    Calabresi, P.
    Arnold, D. L.
    Markowitz, C.
    Shafer, S.
    Kasper, L.
    Waubant, E.
    Gazda, S.
    Fox, R.
    Panzara, M.
    Sarkar, N.
    Agarwal, S.
    Smith, C.
    MULTIPLE SCLEROSIS, 2007, 13 : S165 - S166
  • [39] Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
    Giovannoni, Gavin
    Sorensen, Per Soelberg
    Cook, Stuart
    Rammohan, Kottil
    Rieckmann, Peter
    Comi, Giancarlo
    Dangond, Fernando
    Adeniji, Abidemi K.
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1594 - 1604
  • [40] Clinical results of a phase III trial of oral myelin in relapsing-remitting multiple sclerosis
    Panitch, H
    Francis, G
    ANNALS OF NEUROLOGY, 1997, 42 (03) : T262 - T262
12345